National Health Investors Overview
National Health Investors (NHI) has a ROE of 9373.13%, above the Finance sector average of 16.71%.
Get informed when a big investor buys or sells
+ Follow9373.13%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
National Health Investors's return on equity stands at 9373.13%. That is above the Finance sector average of 16.71%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
National Health Investors sits higher the Finance benchmark (16.71%) with a ROE of 9373.13%. That is roughly 56005.4% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 9373.13% for National Health Investors means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how National Health Investors's ROE evolved across reporting periods, while the comparison chart places NHI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Finance, ROE is commonly used to spot outliers. National Health Investors's reading of 9373.13% (sector avg 16.71%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
